1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
655B54754BCDFC3EB8525835A006EE567
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-in-formulary-success-key-information-that-payers-want-from-field-medical-teams
18
19
2054.161.31.247
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Managed Care Organizations and Winning Practices

Best Practices in Formulary Success: Key Information that Payers want from Field Medical Teams

ID: 5538


Features:

20 Info Graphics

26 Data Graphics

175 Metrics

32 Narratives


Pages/Slides: 51


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Best Practices in Formulary Success: Key Information that Payers want from Field Medical Teams"

STUDY OVERVIEW

As the influence of payers has risen dramatically, pharmaceutical field medical team (FMT) interactions with payers also have risen in importance. The healthcare market is shifting to a value-based system; a new product’s position on a formulary is now as important as its reception among prescribers and KOLs. Recognizing this trend, pharma is paying more attention to the type of information that payers want and, more importantly, the information that will affect formulary decisions.

This study explores what types of information managed care organizations find most important for their formulary decision-making and how they are using the information related to formulary placement.

KEY TOPICS

  • Executive Summary: Methodology, Participants, & Key Findings
  • Information used for Formulary Decisions – How is it used and how is it useful?

KEY METRICS

  • Rate in importance each type of information/data that you use that is provided by outside sources (manufacturers, vendors, etc.)
  • Ratings provided for 21 information/data types (product efficacy & safety, managed care trends, clinical practice guidelines, compendia, comparative data, pricing analysis, etc.)
  • Indicate how you use that information and why it is useful
SAMPLE KEY FINDINGS
  • Similarly, respondents in MCOs and PBMs highly value three types of information for their decision-making:
      1. Product efficacy/safety information
      2. Comparative data and differentiating factors
      3. Clinical practice guidelines
METHODOLOGY

This study engaged a total of 23 formulary leaders from at least 16 managed care organizations. Medical directors represented more than 40% of the respondents.

Industries Profiled:
Insurance; Health Care; Medical


Companies Profiled:
Anthem; Kaiser Permanente; CVS Health; WellSpan Health; DaVita; Aetna; Ascension; Cleveland Clinic; Express Scripts; Inc.; Tenet Healthcare ; Humana; MedImpact; HCA; UnityPoint Health; St. Joseph's Health; University Hospitals


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.